Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024)
Mira Pharmaceuticals (MIRA) posted Current Leases of $1273.0 for Q1 2024, down 74.85% sequentially from $5061.0 in Q4 2023.
Mira Pharmaceuticals (MIRA) Current Leases (2022 - 2024) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 3 years of Current Leases data on file, last reported at $1273.0 in Q1 2024.
- Quarterly Current Leases changed N/A year-over-year to $1273.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1273.0 (changed N/A YoY) and the FY2023 annual result came in at $5061.0, down 93.26% from the prior year.
- Current Leases declined to $1273.0 in Q1 2024 per MIRA's latest filing, from $5061.0 in the prior quarter.
- The five-year high for Current Leases was $75362.0 in Q2 2023, with the low at $1273.0 in Q1 2024.
- Average Current Leases over 3 years is $46233.4, with a median of $74328.0 recorded in 2023.
- The widest YoY moves for Current Leases: up 93.26% in 2023, down 93.26% in 2023.
- Mira Pharmaceuticals' Current Leases stood at $75143.0 in 2022, then slumped by 93.26% to $5061.0 in 2023, then plunged by 74.85% to $1273.0 in 2024.
- Business Quant data shows MIRA's Current Leases at $1273.0 in Q1 2024, $5061.0 in Q4 2023, and $74328.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 271.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1,273.00 |
| Dec 31, 2023 | 5,061.00 |
| Sep 30, 2023 | 74,328.00 |
| Jun 30, 2023 | 75,362.00 |
| Dec 31, 2022 | 75,143.00 |